Healing effects of autologous platelet gel and growth factors on cutaneous leishmaniasis wounds in addition to antimony; a self-controlled clinical trial with randomized lesion assignment. [PDF]
Shadmand E +5 more
europepmc +1 more source
Identification of CβS and ODC antimony resistance markers in anthroponotic cutaneous leishmaniasis field isolates by gene expression profiling. [PDF]
Zarrinkar F +9 more
europepmc +1 more source
Comparison of Intralesional Sodium Stibogluconate versus Intralesional Meglumine Antimoniate for the Treatment of Leishmania major Cutaneous Leishmaniasis. [PDF]
Solomon M +6 more
europepmc +1 more source
Antimony resistance mechanism in genetically different clinical isolates of Indian Kala-azar patients. [PDF]
Khanra S +6 more
europepmc +1 more source
Chronic ulceration as a late manifestation of tropical disease. [PDF]
Janocha-Litwin J +3 more
europepmc +1 more source
Progress in antileishmanial drugs: Mechanisms, challenges, and prospects. [PDF]
Zhang H +9 more
europepmc +1 more source
Cutaneous leishmaniasis presenting with painless ulcer on the right forearm: A case report. [PDF]
Zhuang L, Su J, Tu P.
europepmc +1 more source
Stibanate (sodium antimony gluconate) with pedunculine in the treatment of kalaazar.
Sanyal Sc
openalex +1 more source
Unravelling drug resistance in leishmaniasis: genomic adaptations and emerging therapies. [PDF]
Bhusal CK, Sinha S, Kaur D, Sehgal R.
europepmc +1 more source
The development of a global research agenda and individual participant data platform for visceral leishmaniasis: challenges and future opportunities. [PDF]
Singh-Phulgenda S +14 more
europepmc +1 more source

